Covered recipient · General Payments record
JULIA BRANN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,839.51
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $719.00 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.50 | 13 |
| Indivior Inc. | $148.20 | 9 |
| Alkermes, Inc. | $68.49 | 3 |
| Neuronetics, Inc. | $59.16 | 1 |
| Tempus AI, Inc | $43.92 | 2 |
| ITI, Inc. | $39.50 | 2 |
| Brainsway USA INC | $23.40 | 1 |
| Neurocrine BioSciences, Inc. | $21.24 | 1 |
| Orexo US, Inc. | $20.63 | 1 |
| Lundbeck LLC | $20.42 | 1 |
| Axsome Therapeutics, Inc. | $16.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.07 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815698 | CMS |
| ABBVIE INC. | $32.71 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815700 | CMS |
| ABBVIE INC. | $8.92 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815702 | CMS |
| ABBVIE INC. | $5.20 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815704 | CMS |
| ABBVIE INC. | $10.78 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815706 | CMS |
| ABBVIE INC. | $32.72 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815708 | CMS |
| ABBVIE INC. | $33.90 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815710 | CMS |
| ABBVIE INC. | $7.50 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815712 | CMS |
| ABBVIE INC. | $34.39 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815714 | CMS |
| ABBVIE INC. | $32.72 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815716 | CMS |
| ABBVIE INC. | $4.67 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815718 | CMS |
| ABBVIE INC. | $20.10 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815720 | CMS |
| ABBVIE INC. | $10.82 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106815722 | CMS |
| Alkermes, Inc. | $22.52 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120470830 | CMS |
| Alkermes, Inc. | $22.18 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120470832 | CMS |
| Alkermes, Inc. | $23.79 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120470834 | CMS |
| Axsome Therapeutics, Inc. | $16.54 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148372849 | CMS |
| Brainsway USA INC | $23.40 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120090450 | CMS |
| Indivior Inc. | $18.20 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545199 | CMS |
| Indivior Inc. | $22.33 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545201 | CMS |
| Indivior Inc. | $15.29 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545203 | CMS |
| Indivior Inc. | $14.60 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545205 | CMS |
| Indivior Inc. | $16.20 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545207 | CMS |
| Indivior Inc. | $13.38 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545209 | CMS |
| Indivior Inc. | $17.10 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545211 | CMS |
| Indivior Inc. | $15.66 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545213 | CMS |
| Indivior Inc. | $15.44 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144545215 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143384611 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.89 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143384614 | CMS |
| Lundbeck LLC | $20.42 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145998010 | CMS |
| Neurocrine Biosciences, Inc. | $21.24 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150973521 | CMS |
| Neuronetics, Inc. | $59.16 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1073311872 | CMS |
| Orexo US, Inc. | $20.63 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177938 | CMS |
| Tempus AI, Inc | $21.13 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150178991 | CMS |
| Tempus AI, Inc | $22.79 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150178993 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.